/
OACC
$10.70+$0.03 (+0.28%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$262.3M
25M shares
52-week range
$10.30 – $10.74
92% from low
Sector
BLANK CHECKS
Exchange
NASDAQ
CS
Borrow rate
3.92%
Moderate
Price (6 mo)
Loading chart…
Change+$0.70
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2024 | 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$703 | −$1.2M |
| EBITDA | −$351.8K | −$1.2M |
| Net income | $2.7K | $7.3M |
| Net margin | — | — |
| EPS (diluted) | 0.05 | 0.30 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp III Life Sciences is a blank check company.
www.oaktreeacquisitioncorp.com- IPO / List date
- Dec 16, 2024
- HQ
- LOS ANGELES, CA
Held by traders on TradeandTell
No one on the platform currently holds OACC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in OACC as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded OACC yet.